| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/05/2006 | WO2006103353A1 Device for producing a foam formed by gas bubbles and a surfactant liquid |
| 10/05/2006 | WO2006103198A2 Ophthalmic composition |
| 10/05/2006 | WO2006103112A2 Method for treating prostate diseases based on local delivery of active substances |
| 10/05/2006 | WO2006103011A1 Pharmaceutical preparation of n -[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide |
| 10/05/2006 | WO2006102965A1 Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
| 10/05/2006 | WO2006102800A1 Nano-micellar preparation of anthracycline antitumor antibiotics wrapped by the polyethylene glycols derivative of phosphatide |
| 10/05/2006 | WO2006102768A1 Colloidal solid lipid vehicle for pharmaceutical use |
| 10/05/2006 | WO2006102748A1 Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 10/05/2006 | WO2006085335A3 Pharmaceutical composition of acid labile substances |
| 10/05/2006 | WO2006085168A3 Solid oral dosage forms of ziprasidone containing colloidal silicone dioxide |
| 10/05/2006 | WO2006055511A3 Stable tablet formulation of tetrahydrobiopterin |
| 10/05/2006 | WO2006053225A3 Protein-noble metal nanoparticles |
| 10/05/2006 | WO2006040141A3 Segmented device for the delayed release of molecules in a tangential direction through thin films and uses thereof |
| 10/05/2006 | WO2006026935A3 Pharmaceutical composition for rectal or vaginal application comprising a platinum complex |
| 10/05/2006 | WO2006021122A3 Polyvinyl alcohol gels, especially in situ gelling gels |
| 10/05/2006 | WO2006004418A3 Encapsulated tobacco smoke |
| 10/05/2006 | WO2005117561A3 Compositions and methods for diagnosing and treating diseases using low density lipoprotein-like lipid emulsions |
| 10/05/2006 | WO2005107702A3 Sustained release, mucoadhesive vaginal pharmaceutical compositions |
| 10/05/2006 | WO2005062818A8 Treatment of ophthalmic conditions |
| 10/05/2006 | WO2005058284A9 Fast-disintegrating tablets |
| 10/05/2006 | WO2005044239A3 Osmotic pump with self-retaining, fast-start membrane plug |
| 10/05/2006 | WO2004098454A3 Low profile components for patient infusion device |
| 10/05/2006 | US20060224145 Device and method for accurate delivery of an active agent |
| 10/05/2006 | US20060224141 Method and system for providing integrated medication infusion and analyte monitoring system |
| 10/05/2006 | US20060224108 Optimized sensor geometry for an implantable glucose sensor |
| 10/05/2006 | US20060223870 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
| 10/05/2006 | US20060223865 Therapeutic combination |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223776 Crosslinking compound releasing drug in acidity environment; for use as vaccines or therapeutic agents |
| 10/05/2006 | US20060223770 IRNA agents targeting VEGF |
| 10/05/2006 | US20060223769 Vaccines using nucleic acid-lipid complexes |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060223740 Absorption enhancers such as e.g. bht, bha or propyl gallate |
| 10/05/2006 | US20060223156 Controlled dissolution crosslinked protein in crystals |
| 10/05/2006 | US20060222766 Encapsulation system |
| 10/05/2006 | US20060222718 Aqueous pharmaceutical solution comprising oxymetazoline and/or xylometazoline |
| 10/05/2006 | US20060222716 Colloidal solid lipid vehicle for pharmaceutical use |
| 10/05/2006 | US20060222715 Particles containing an acitve agent in the form of a co-precipitate |
| 10/05/2006 | US20060222714 Agent for preventing and ameliorating constipation |
| 10/05/2006 | US20060222713 Extended release pharmaceutical composition of phenytoin sodium |
| 10/05/2006 | US20060222712 Acne gel |
| 10/05/2006 | US20060222711 Composition of and method for preparing stable particles in a frozen aqueous matrix |
| 10/05/2006 | US20060222710 Composition of and method for preparing stable particles in a frozen aqueous matrix |
| 10/05/2006 | US20060222709 Metformin methods and formulations for treating chronic constipation |
| 10/05/2006 | US20060222708 Wafer comprising steroid hormones |
| 10/05/2006 | US20060222707 Formulations of fenofibrate |
| 10/05/2006 | US20060222706 Formulations of Fenofibrate |
| 10/05/2006 | US20060222705 Pharmaceutical tablet and apparatus and method for making |
| 10/05/2006 | US20060222704 System and a method for labeling a substrate |
| 10/05/2006 | US20060222703 Pharmaceutical composition and preparation method thereof |
| 10/05/2006 | US20060222702 System and method for optically tracking objects using a spectral fingerprint of fluorescent compounds |
| 10/05/2006 | US20060222701 Compositions with hydrophilic drugs in a hydrophobic medium |
| 10/05/2006 | US20060222700 Tablet and capsule form of liquid active ingredient |
| 10/05/2006 | US20060222699 Flavored vegetarian cellulose capsule and methods for producing said capsule. |
| 10/05/2006 | US20060222698 hepatocyte targeted composition comprising mixture of free recombinant human insulin isophane and free recombinant human regular insulin and mixture of recombinant human insulin isophane and recombinant human regular insulin associated with water insoluble target molecule complex; diabetes treatment |
| 10/05/2006 | US20060222697 Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal |
| 10/05/2006 | US20060222696 comprising one or more phosphatidylcholines, an N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, a targeting factor-modified N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, an encapsulated drug, cholesterol; cancer treatment |
| 10/05/2006 | US20060222695 Deoxycholic acid liposome-based dermatological topical preparation |
| 10/05/2006 | US20060222694 Stabilized topotecan liposomal composition and methods |
| 10/05/2006 | US20060222693 Transdermal patch bearing a decorative image |
| 10/05/2006 | US20060222692 Method and compositions for transdermal administration of antimicrobial medications |
| 10/05/2006 | US20060222691 Composition for the transdermal delivery of fentanyl |
| 10/05/2006 | US20060222689 vitamin C, vitamin B complex, carotene, vitamin E, a fragrance, a thickener and a surfactant; acne treamtent |
| 10/05/2006 | US20060222688 Disposable gloves |
| 10/05/2006 | US20060222687 Topical anesthetic |
| 10/05/2006 | US20060222686 Dry products comprising an applicator and a wax phase |
| 10/05/2006 | US20060222684 Palatable ductile chewable veterinary composition |
| 10/05/2006 | US20060222683 A soft, pliable, dissolvable candy,(Gummi-Bears) having an oval shape where a plurality of hard segments-like ridges are formed on a surface of the soft candy which afford an abrasive scraping action on the tongue as the candy is eaten; covering power; cleaning compounds; denistry |
| 10/05/2006 | US20060222682 Nutraceutical Moringa composition |
| 10/05/2006 | US20060222677 Method of protecting sensitive molecules from a photo-polymerizing environment |
| 10/05/2006 | US20060222673 Injectable phosphatidylcholine preparations |
| 10/05/2006 | US20060222669 Use of tin (IV) mesoporphyrin IX dichloride in an aqueous solution having a physiological osmolarity for treatment of hyperbilirubinemia, elevated serum bilirubin concentration, jaundice; shelf life |
| 10/05/2006 | US20060222668 Stannsoporfin compositions, drug products and methods of manufacture |
| 10/05/2006 | US20060222662 Composition to be administered to a living being and method for marking agents |
| 10/05/2006 | US20060222655 Compositions and methods for preventing and treating endotoxin-related diseases and conditions |
| 10/05/2006 | US20060222599 Inhalative powder formulations containing the CGRP-antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine |
| 10/05/2006 | US20060222598 Scopine 2,2-diphenylpropionate-metho halides and other salts: propellant-free solution with ethanol and water and an acid; optimum nebulization; storage stability; nebulizer |
| 10/05/2006 | US20060222597 Buccal, polar and non-polar sprays containing propofol |
| 10/05/2006 | US20060222595 Nanoparticles for therapeutic and diagnostic applications |
| 10/05/2006 | US20060219242 Method for the Administration of an Anticholinergic by Inhalation |
| 10/05/2006 | DE102005042782A1 Kaugummiprodukte, die ein Trigeminus-Stimulans enthalten, und Verfahren zu ihrer Herstellung Chewing gum products containing a trigeminal stimulant, and processes for their preparation |
| 10/05/2006 | DE102005015128A1 Wafer enthaltend Steroidhormone Wafer containing steroid hormones |
| 10/05/2006 | CA2634038A1 Liposome composition for immune induction |
| 10/05/2006 | CA2603433A1 Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
| 10/05/2006 | CA2603334A1 Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 10/05/2006 | CA2603313A1 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same |
| 10/05/2006 | CA2603235A1 Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
| 10/05/2006 | CA2603105A1 Controlled absorption of statins in the intestine |
| 10/05/2006 | CA2603002A1 Spherically shaped substances |
| 10/05/2006 | CA2602832A1 Low-concentration capsaicin patch and methods for treating neuropathic pain |
| 10/05/2006 | CA2602776A1 Method for treating prostate diseases based on local delivery of active substances |
| 10/05/2006 | CA2602750A1 Pharmaceutical preparation of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide |
| 10/05/2006 | CA2601339A1 Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
| 10/05/2006 | CA2600282A1 Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
| 10/05/2006 | CA2599386A1 New pharmaceutical compositions useful in the treatment of pain |
| 10/05/2006 | CA2599384A1 New pharmaceutical compositions useful in the treatment of parkinson's disease |
| 10/05/2006 | CA2598892A1 Tablet containing steroid hormones |
| 10/04/2006 | EP1707630A1 Antisense oligonucleotide having anticancerous activity |
| 10/04/2006 | EP1707225A2 Methods and compositions for treating intervertebral disc degeneration |
| 10/04/2006 | EP1707209A1 The traditional chinese medicine preparation for treatment of tumour and method of making and using same |